Active Antiviral Treatment for Chronic Hepatitis C Virus Infection Needs to be Recommended for Decreasing Hepatitis C-Associated Hepatocellular Carcinoma Risk in the New Era of Highly Effective Oral Antiviral Drugs

2016 ◽  
Vol 64 (2) ◽  
pp. S830
Author(s):  
Y.-J. Jin ◽  
J.T. Hong ◽  
J.-W. Lee
Keyword(s):  
Hepatocellular Carcinoma ◽  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Antiviral Treatment ◽  
Hepatitis C Virus Infection ◽  
New Era ◽  
Chronic Hepatitis C Virus ◽  
Carcinoma Risk

scholarly journals Nem invazív fibrosisdiagnosztika hepatitis C-vírus-infekcióban: szerepe a kezelés indikációjában, követésében és a prognózis megítélésében

2015 ◽  
Vol 156 (21) ◽  
pp. 855-861 ◽  
Author(s):  
Alajos Pár ◽  
Áron Vincze ◽  
Gabriella Pár
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Liver Biopsy ◽  
Chronic Hepatitis C ◽  
Antiviral Treatment ◽  
Hepatitis C Virus Infection ◽  
Non Invasive ◽  
Chronic Hepatitis C Virus

Chronic hepatitis C virus infection associated with necroinflammation predisposes to liver fibrosis and cirrhosis, which lead to severe end-stage complications. Staging of fibrosis is of basic importance for the indication of antiviral treatment, for monitoring the response and predicting the prognosis of patients with hepatitis C virus related liver disease. Since liver biopsy, the “gold standard” diagnosis of fibrosis is invasive and it has some other limitations, non-invasive methods have been developed and widely used in the clinical practice. Serum biomarkers and physical approaches measuring liver stiffness by elastography as well as combination algorithms have been gradually been integrated into guidelines resulting in a reduction of the need for liver biopsy. The authors review these non-invasive fibrosis markers and discuss their role in the indication of treatment, follow-up, and assessment of prognosis of patients with chronic hepatitis C virus infection. Orv. Hetil., 2015, 156(21), 855–861.

scholarly journals Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection

Hepatology ◽  
2010 ◽  
Vol 52 (2) ◽  
pp. 518-527 ◽  
Author(s):  
Yasuhiro Asahina ◽  
Kaoru Tsuchiya ◽  
Nobuharu Tamaki ◽  
Itsuko Hirayama ◽  
Tomohiro Tanaka ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Chronic Hepatitis C ◽  
Hepatitis C Virus Infection ◽  
Chronic Hepatitis C Virus
Sign in / Sign up

Export Citation Format

Share Document